STE Form 4: Shah Nirav R Receives 1,407 Options at $242.85 and 487 RSUs

Rhea-AI Filing Summary

STERIS plc director Shah Nirav R reported insider transactions on 08/08/2025 showing a grant of 1,407 nonqualified stock options with a $242.85 exercise price and an expiration date of 08/08/2035. The filing states these options are fully vested and exercisable immediately. The report also shows 487 Career Restricted Stock Units that are fully vested and will be settled in ordinary shares six months after the cessation of the director's board service. The filing records 1,407 options and 6,503 derivative securities beneficially owned following the reported transactions.

Positive

• Options are fully vested and exercisable immediately, providing clear rights to the reporting person.
• Career Restricted Stock Units are fully vested and include explicit settlement timing (six months after board service ends).

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine director equity grants; options vested immediately, RSUs settle after board service ends.

The Form 4 discloses a director-level equity award package executed on 08/08/2025. Key specifics: 1,407 nonqualified stock options at an exercise price of $242.85 expiring 08/08/2035, and 487 Career Restricted Stock Units that are fully vested and convert to ordinary shares six months after board service termination. The options are explicitly stated as fully vested and exercisable immediately, which is material to near-term insider liquidity but is a standard governance compensation action.

Corporate Governance Expert

TL;DR: Disclosure reflects standard director compensation with clear vesting and settlement terms.

The filing identifies the reporting person as Shah Nirav R in the role of Director. The Career RSUs include a delayed settlement condition: they will be settled in ordinary shares six months after the director leaves the board. The Form 4 is signed via authorized representative on 08/12/2025. The disclosure provides transparent timelines and amounts for equity awards, enabling shareholders to track potential future share issuance tied to RSU settlement conditions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shah Nirav R

(Last) (First) (Middle)

C/O 70 SIR JOHN ROGERSON'S QUAY

(Street)

DUBLIN 2 L2 D02 R296

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
STERIS plc [ STE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Director Stock Option (right to buy)	$242.85	08/08/2025		A		1,407		(1)	08/08/2035	Ordinary Shares	1,407	$0	1,407	D
Career Restricted Stock Units	(2)	08/08/2025		A		487		(3)	(3)	Ordinary Shares	487	$0	6,503	D

Explanation of Responses:

1. These nonqualified stock options are fully vested and are exercisable immediately.

2. Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.

3. These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.

Remarks:

	/s/ John P. Ubbing, Authorized Representative under Power of Attorney	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Shah Nirav R report on Form 4 for STERIS (STE)?

The Form 4 reports a grant of 1,407 nonqualified stock options and 487 Career Restricted Stock Units, both reported with a transaction date of 08/08/2025.

What are the terms of the stock options reported on the Form 4?

The options have an exercise price of $242.85, are stated as fully vested and exercisable immediately, and expire on 08/08/2035.

When will the reported Career Restricted Stock Units (RSUs) be settled?

Each Career RSU converts to one ordinary share and will be settled six months after the cessation of the director's board service; the RSUs are reported as fully vested.

How many derivative securities are reported as beneficially owned after the transactions?

The filing shows 1,407 derivative securities for the stock options and 6,503 derivative securities beneficially owned following the reported transactions.

Who filed the Form 4 and when was it signed?

The reporting person is Shah Nirav R identified as a Director. The form is signed by an authorized representative on 08/12/2025.